DOCSLIB.ORG

Dermatology ICD 10

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dermatology ICD 10 Dermatology ICD 10 PATIENT NAME: DOB: APPOINTMENT DATE: √ CODE NEW PATIENT VISIT √ CODE ESTABLISHED PATIENT VISIT √ CODE CONSULTATIONS 99201 Problem Focused 99211 Nurse/MD Visit 99241 Problem Focused 99202 Expanded Problem Focused 99212 Problem Focused 99242 Expanded Problem Focused 99203 Detailed 99213 Expanded Problem Focused 99243 Detailed 99204 Comprehensive 99214 Detailed 99244 Comprehensive 99205 Comprehensive 99215 Comprehensive 99245 Comprehensive NEOPLASM SKIN DISORDER DERMATIITIS C44.311 Basal cell carcinoma of skin of nose B07.9 Viral wart, unspecified L21.9 Seborrheic dermatitis, unspecified Basal cell carcinoma of skin of other parts C44.319 of face B35.5 Tinea imbricata L20.9 Atopic dermatitis, unspecified Hemangioma of skin and subcutaneous Allergic contact dermatitis, unspecified C44.510 Basal cell carcinoma of anal skin D18.01 tissue L23.9 cause Irritant contact dermatitis, unspecified C44.511 Basal cell carcinoma of skin of breast D69.2 Other nonthrombocytopenic purpura L24.9 cause Basal cell carcinoma of skin of other part of Other specified acute skin changes due to C44.519 trunk L56.8 ultraviolet radiation L30.0 Nummular dermatitis Basal cell carcinoma of skin of right upper Acute skin change due to ultraviolet C44.612 limb, including shoulder L56.9 radiation, unspecified L30.8 Other specified dermatitis Basal cell carcinoma of skin of left upper C44.619 limb, including shoulder L30.2 Cutaneous autosensitization L30.9 Dermatitis, unspecified Basal cell carcinoma of overlapping sites of C44.81 skin L71.1 Rhinophyma L71.0 Perioral dermatitis Squamous cell carcinoma of skin of right C44.622 upper limb, including shoulder L71.8 Other rosacea L26 Exfoliative dermatitis Squamous cell carcinoma of skin of left C44.629 upper limb, including shoulder L30.4 Erythema intertrigo Squamous cell carcinoma of skin of right C44.722 lower limb, including hip L53.8 Other specified erythematous conditions Squamous cell carcinoma of skin of left C44.729 lower limb, including hip L54 Erythema in diseases classified elsewhere Squamous cell carcinoma of overlapping APPOINTMENTS AND TESTS TO BE C44.82 sites of skin L92.0 Granuloma annulare SCHEDULED D23.5 Other benign neoplasm of skin of trunk L95.1 Erythema elevatum diutinum Other benign neoplasm of skin of right D23.71 lower limb, including hip L98.2 Febrile neutrophilic dermatosis [Sweet] Other benign neoplasm of skin of left lower D23.72 limb, including hip L29.9 Pruritus, unspecified D22.5 Melanocytic nevi of trunk L85.9 Epidermal thickening, unspecified Melanocytic nevi of right lower limb, Transepidermal elimination disorder, D22.71 including hip L87.9 unspecified Melanocytic nevi of left lower limb, including D22.72 hip L90.9 Atrophic disorder of skin, unspecified Hypertrophic disorder of the skin, D48.5 Neoplasm of uncertain behavior of skin L91.9 unspecified Neoplasm of unspecified behavior of bone, Localized connective tissue disorder, D49.2 soft tissue, and skin L94.9 unspecified L57.0 Actinic keratosis L82.0 Inflamed seborrheic keratosis ACNE L82.1 Other seborrheic keratosis OTHER L70.0 Acne vulgaris L64.9 Androgenic alopecia, unspecified L70.1 Acne conglobata L66.3 Perifolliculitis capitis abscedens L70.3 Acne tropica L73.1 Pseudofolliculitis barbae L70.4 Infantile acne L73.8 Other specified follicular disorders L70.8 Other acne L81.0 Postinflammatory hyperpigmentation L73.0 Acne keloid L81.1 Chloasma L81.2 Freckles L81.3 Cafe au lait spots CYST L81.4 Other melanin hyperpigmentation L72.0 Epidermal cyst Other disorders of diminished melanin L72.2 Steatocystoma multiplex formation L72.3 Sebaceous cyst Other follicular cysts of the skin and L72.8 subcutaneous tissue PSORIASIS L40.0 Psoriasis vulgaris L40.1 Generalized pustular psoriasis L40.2 Acrodermatitis continua.
Load more

Recommended publications
  • Rapid Development of Perifolliculitis Following Mesotherapy
    CASE LETTER Rapid Development of Perifolliculitis Following Mesotherapy Weihuang Vivian Ning, MD; Sameer Bashey, MD; Gene H. Kim, MD patient received mesotherapy with an unknown substance PRACTICE POINTS for cosmetic rejuvenation; the rash was localized only to the injection sites.copy She did not note any fever, chills, • Mesotherapy—the delivery of vitamins, chemicals, and plant extracts directly into the dermis via nausea, vomiting, diarrhea, headache, arthralgia, or upper injections—is a common procedure performed respiratory tract symptoms. She further denied starting in both medical and nonmedical settings for any new medications, herbal products, or topical therapies cosmetic rejuvenation. apart from the procedure she had received 2 weeks prior. • Complications can occur from mesotherapy treatment. Thenot patient was found to be in no acute distress and • Patients should be advised to seek medical care with vital signs were stable. Laboratory testing was remarkable US Food and Drug Administration–approved cosmetic for elevations in alanine aminotransferase (62 U/L [refer- techniques and substances only. ence range, 10–40 U/L]) and aspartate aminotransferase (72 U/L [reference range 10–30 U/L]). Moreover, she had Doan absolute neutrophil count of 0.5×103 cells/µL (refer- ence range 1.8–8.0×103 cells/µL). An electrolyte panel, To the Editor: creatinine level, and urinalysis were normal. Physical Mesotherapy, also known as intradermotherapy, is a examination revealed numerous 4- to 5-mm erythematous cosmetic procedure in which multiple
    [Show full text]
  • Pediatric and Adolescent Dermatology
    Pediatric and adolescent dermatology Management and referral guidelines ICD-10 guide • Acne: L70.0 acne vulgaris; L70.1 acne conglobata; • Molluscum contagiosum: B08.1 L70.4 infantile acne; L70.5 acne excoriae; L70.8 • Nevi (moles): Start with D22 and rest depends other acne; or L70.9 acne unspecified on site • Alopecia areata: L63 alopecia; L63.0 alopecia • Onychomycosis (nail fungus): B35.1 (capitis) totalis; L63.1 alopecia universalis; L63.8 other alopecia areata; or L63.9 alopecia areata • Psoriasis: L40.0 plaque; L40.1 generalized unspecified pustular psoriasis; L40.3 palmoplantar pustulosis; L40.4 guttate; L40.54 psoriatic juvenile • Atopic dermatitis (eczema): L20.82 flexural; arthropathy; L40.8 other psoriasis; or L40.9 L20.83 infantile; L20.89 other atopic dermatitis; or psoriasis unspecified L20.9 atopic dermatitis unspecified • Scabies: B86 • Hemangioma of infancy: D18 hemangioma and lymphangioma any site; D18.0 hemangioma; • Seborrheic dermatitis: L21.0 capitis; L21.1 infantile; D18.00 hemangioma unspecified site; D18.01 L21.8 other seborrheic dermatitis; or L21.9 hemangioma of skin and subcutaneous tissue; seborrheic dermatitis unspecified D18.02 hemangioma of intracranial structures; • Tinea capitis: B35.0 D18.03 hemangioma of intraabdominal structures; or D18.09 hemangioma of other sites • Tinea versicolor: B36.0 • Hyperhidrosis: R61 generalized hyperhidrosis; • Vitiligo: L80 L74.5 focal hyperhidrosis; L74.51 primary focal • Warts: B07.0 verruca plantaris; B07.8 verruca hyperhidrosis, rest depends on site; L74.52 vulgaris (common warts); B07.9 viral wart secondary focal hyperhidrosis unspecified; or A63.0 anogenital warts • Keratosis pilaris: L85.8 other specified epidermal thickening 1 Acne Treatment basics • Tretinoin 0.025% or 0.05% cream • Education: Medications often take weeks to work AND and the patient’s skin may get “worse” (dry and red) • Clindamycin-benzoyl peroxide 1%-5% gel in the before it gets better.
    [Show full text]
  • The Diagnosis and Management of Mild to Moderate Pediatric Acne Vulgaris
    The Diagnosis and Management of Mild to Moderate Pediatric Acne Vulgaris Successful management of acne vulgaris requires a comprehensive approach to patient care. By Joseph B. Bikowski, MD s a chronic, inflammatory skin disorder affect- seek treatment, males tend to have more severe pre- ing susceptible pilosebaceous units of the face, sentations. Acne typically begins between seven and Aneck, shoulders, and upper trunk, acne pres- 10 years of age and peaks between the ages of 16-19 ents unique challenges for patients and clini- years. A majority of patients clear by 20-25 years of cians. Characterized by both non-inflammatory and age, however some patients continue to have acne inflammatory lesions, three types of acne have been beyond 40 years of age. So-called “adult acne,” per- identified: neonatal acne, infantile acne, and acne sisting beyond the early-to-mid 20s, is more common vulgaris; pediatric acne vulgaris is the focus of this in women than in men. Given the hormonal media- article. Successful management of mild to moderate tors involved, acne onset correlates better with acne vulgaris requires a comprehensive approach to pubertal age than with chronological age. patient care that emphasizes 1.) education, 2.) prop- er skin care, and 3.) targeted therapy aimed at the Take-Home Tips. Successful management of mild to moderate underlying pathogenic factors that contribute to acne vulgaris requires a comprehensive approach to patient care that acne. Early initiation of effective therapy is essential emphasizes 1.) education, 2.) proper skin care, and 3.) targeted to minimize the emotional impact of acne on a therapy aimed at underlying pathogenic factors that contribute to patient, improve clinical outcomes, and prevent acne.
    [Show full text]
  • General Dermatology an Atlas of Diagnosis and Management 2007
    An Atlas of Diagnosis and Management GENERAL DERMATOLOGY John SC English, FRCP Department of Dermatology Queen's Medical Centre Nottingham University Hospitals NHS Trust Nottingham, UK CLINICAL PUBLISHING OXFORD Clinical Publishing An imprint of Atlas Medical Publishing Ltd Oxford Centre for Innovation Mill Street, Oxford OX2 0JX, UK tel: +44 1865 811116 fax: +44 1865 251550 email: [email protected] web: www.clinicalpublishing.co.uk Distributed in USA and Canada by: Clinical Publishing 30 Amberwood Parkway Ashland OH 44805 USA tel: 800-247-6553 (toll free within US and Canada) fax: 419-281-6883 email: [email protected] Distributed in UK and Rest of World by: Marston Book Services Ltd PO Box 269 Abingdon Oxon OX14 4YN UK tel: +44 1235 465500 fax: +44 1235 465555 email: [email protected] © Atlas Medical Publishing Ltd 2007 First published 2007 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, without the prior permission in writing of Clinical Publishing or Atlas Medical Publishing Ltd. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention. A catalogue record of this book is available from the British Library ISBN-13 978 1 904392 76 7 Electronic ISBN 978 1 84692 568 9 The publisher makes no representation, express or implied, that the dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up-to-date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations.
    [Show full text]
  • Acne in Childhood: an Update Wendy Kim, DO; and Anthony J
    FEATURE Acne in Childhood: An Update Wendy Kim, DO; and Anthony J. Mancini, MD cne is the most common chron- ic skin disease affecting chil- A dren and adolescents, with an 85% prevalence rate among those aged 12 to 24 years.1 However, recent data suggest a younger age of onset is com- mon and that teenagers only comprise 36.5% of patients with acne.2,3 This ar- ticle provides an overview of acne, its pathophysiology, and contemporary classification; reviews treatment op- tions; and reviews recently published algorithms for treating acne of differing levels of severity. Acne can be classified based on le- sion type (morphology) and the age All images courtesy of Anthony J. Mancini, MD. group affected.4 The contemporary Figure 1. Comedonal acne. This patient has numerous closed comedones (ie, “whiteheads”). classification of acne based on sev- eral recent reviews is addressed below. Acne lesions (see Table 1, page 419) can be divided into noninflammatory lesions (open and closed comedones, see Figure 1) and inflammatory lesions (papules, pustules, and nodules, see Figure 2). The comedone begins with Wendy Kim, DO, is Assistant Professor of In- ternal Medicine and Pediatrics, Division of Der- matology, Loyola University Medical Center, Chicago. Anthony J. Mancini, MD, is Professor of Pediatrics and Dermatology, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children’s Hospital of Chi- cago. Address correspondence to: Anthony J. Man- Figure 2. Moderate mixed acne. In this patient, a combination of closed comedones, inflammatory pap- ules, and pustules can be seen. cini, MD, Division of Dermatology Box #107, Ann and Robert H.
    [Show full text]
  • Steatocystoma-Multiplex.Pdf
    Steatocystoma multiplex Description Steatocystoma multiplex is a skin disorder characterized by the development of multiple noncancerous (benign) cysts known as steatocystomas. These growths begin in the skin's sebaceous glands, which normally produce an oily substance called sebum that lubricates the skin and hair. Steatocystomas are filled with sebum. In affected individuals, steatocystomas typically first appear during adolescence and are found most often on the torso, neck, upper arms, and upper legs. These cysts are usually the only sign of the condition. However, some affected individuals also have mild abnormalities involving the teeth or the fingernails and toenails. Frequency Although the prevalence of steatocystoma multiplex is unknown, it appears to be rare. Causes Steatocystoma multiplex can be caused by mutations in the KRT17 gene. This gene provides instructions for making a protein called keratin 17, which is produced in the nails, the hair follicles, and the skin on the palms of the hands and soles of the feet. It is also found in the skin's sebaceous glands. Keratin 17 partners with a similar protein called keratin 6b to form networks that provide strength and resilience to the skin, nails, and other tissues. The KRT17 gene mutations that cause steatocystoma multiplex alter the structure of keratin 17, preventing it from forming strong, stable networks within cells. The defective keratin network disrupts the growth and function of cells in the skin and nails, including cells that make up the sebaceous glands. These abnormalities lead to the growth of sebum-containing cysts in people with steatocystoma multiplex. However, it is unclear why steatocystomas are typically the only feature of this disorder.
    [Show full text]
  • Steatocystoma Multiplex-A Rare Genetic Disorder: a Case Report and Review of the Literature Pathology Section
    Case Report DOI: 10.7860/JCDR/2012/4691.2698 Steatocystoma Multiplex-A Rare Genetic Disorder: A Case Report and Review of the Literature Pathology Section HEMLATA T. KAMRA, PRADEEP A. GADGIL, AJAY G. OVHAL, RAHUL R. NARKHEDE ABSTRACT is asymptomatic, is a cosmetic threat to the patient . Only a A 17 years old female presented with multiple asymptomatic few cases of the patients with an autosomal dominant mutation, cutaneous cysts all over body, sparing the head and neck who had keratin 17, have been reported. We are reporting here, region. The microscopic examination of the cysts showed the a case of steatocystoma multiplex in a 17 years old female, features of steatocystoma multiplex. This disorder, although it along with its review of literature. Key Words: Steatocystoma, Autosomal dominant, Radiofrequency probe INTRODUCTION On examination, the dermal cysts were found to be round to oval, Steatocystoma multiplex is a rare genetic disorder with an well defined and smooth surfaced, without a punctum and to vary autosomal dominant type of inheritance which usually presents in in diameter from 2-5mm [Table/Fig-1]. The patient gave a history adolescence or is sporadic in nature. Rare cases with an autosomal of similar lesions in her father too. The systemic and the laboratory dominant pattern of inheritance have been published till now [1]. findings were normal. Sonography revealed multiple nodules The disease presents with multiple asymptomatic cysts on the which were oval in shape, which were relatively well marginated axilla, groin, trunk, scrotum and the proximal extremities because and hypoechoic and with a posterior enhancement.
    [Show full text]
  • Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks
    Supplementary Online Content Tschandl P, Rosendahl C, Akay BN, et al. Expert-level diagnosis of nonpigmented skin cancer by combined convolutional neural networks. JAMA Dermatol. Published online November 28, 2018. doi:10.1001/jamadermatol.2018.4378 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set eAppendix. Neural Network Training eTable 1. Complete List of Diagnoses and Their Frequencies Within the Test-Set eTable 2. Education of Users According to Their Experience Group eTable 3. Percent of Correct Prediction of the Malignancy Status for Specific Diagnoses of a CNN Using Either Close-up or Dermatoscopic Images This supplementary material has been provided by the authors to give readers additional information about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set A threshold cut at 0.2 (black) is found for a minimum of 51.3% specificity. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eAppendix. Neural Network Training We compared multiple architecture and training hyperparameter combinations in a grid-search fashion, and used only the single best performing network for dermoscopic and close-up images, based on validation accuracy, for further analyses. We trained four different CNN architectures (InceptionResNetV2, InceptionV3, Xception, ResNet50) and used model definitions and ImageNet pretrained weights as available in the Tensorflow (version 1.3.0)/ Keras (version 2.0.8) frameworks.
    [Show full text]
  • Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex
    Original Article Journal of Cutaneous Medicine and Surgery 00(0) 1–5 Coexistence of Hidradenitis Suppurativa © The Author(s) 2021 and Steatocystoma Multiplex; Is It a New Article reuse guidelines: Variant of Hidradenitis Suppurativa? sagepub. com/ journals- permissions DOI: 10. 1177/ 1203 4754 2110 10145 journals. sagepub. com/ home/ cms 1 2 Joshua Fletcher , Claudia Posso- De Los Rios , 3 4 Jadranka Jambrosic , and Afsaneh Alavi Abstract Hidradenitis suppurativa and steatocystoma multiplex may coexist in the same patient. The overlap of these 2 conditions could be suggestive of an unrecognized defect in follicular proliferation mutual in the pathogenesis of both conditions. Here we present 5 patients with both hidradenitis suppurativa and steatocystoma multiplex. Recognizing the overlap between these 2 conditions is important for accurate diagnosis, management, and identification of potential surgical candidates, as well as future basic science research. Keywords dermatology, inflammatory dermatoses Introduction its natural history, mimicking both hidradenitis suppura- tiva and acne conglobata.4,10 Hidradenitis suppurative (HS) is a chronic, inflammatory, The overlap of HS and SM, or SMS, could be sugges- recurrent disease affecting the folliculopilosebaceous unit tive of an unrecognized defect in follicular proliferation in the apocrine gland-bearing areas. This leads to comedo- common to both diseases or a mutual genetic link. 1 nes, nodules, abscesses, sinus tracts, and scarring. HS Recognizing this overlap is important for an accurate usually presents in a sporadic or familial fashion, but rare diagnosis, management and identification of potential sur- syndromic forms recognizable for their unique symptom- gical candidates, as well as future basic science research. 2 atology have been described in the literature.
    [Show full text]
  • Pili Torti: a Feature of Numerous Congenital and Acquired Conditions
    Journal of Clinical Medicine Review Pili Torti: A Feature of Numerous Congenital and Acquired Conditions Aleksandra Hoffmann 1 , Anna Wa´skiel-Burnat 1,*, Jakub Z˙ ółkiewicz 1 , Leszek Blicharz 1, Adriana Rakowska 1, Mohamad Goldust 2 , Małgorzata Olszewska 1 and Lidia Rudnicka 1 1 Department of Dermatology, Medical University of Warsaw, Koszykowa 82A, 02-008 Warsaw, Poland; [email protected] (A.H.); [email protected] (J.Z.);˙ [email protected] (L.B.); [email protected] (A.R.); [email protected] (M.O.); [email protected] (L.R.) 2 Department of Dermatology, University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany; [email protected] * Correspondence: [email protected]; Tel.: +48-22-5021-324; Fax: +48-22-824-2200 Abstract: Pili torti is a rare condition characterized by the presence of the hair shaft, which is flattened at irregular intervals and twisted 180◦ along its long axis. It is a form of hair shaft disorder with increased fragility. The condition is classified into inherited and acquired. Inherited forms may be either isolated or associated with numerous genetic diseases or syndromes (e.g., Menkes disease, Björnstad syndrome, Netherton syndrome, and Bazex-Dupré-Christol syndrome). Moreover, pili torti may be a feature of various ectodermal dysplasias (such as Rapp-Hodgkin syndrome and Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome). Acquired pili torti was described in numerous forms of alopecia (e.g., lichen planopilaris, discoid lupus erythematosus, dissecting Citation: Hoffmann, A.; cellulitis, folliculitis decalvans, alopecia areata) as well as neoplastic and systemic diseases (such Wa´skiel-Burnat,A.; Zółkiewicz,˙ J.; as cutaneous T-cell lymphoma, scalp metastasis of breast cancer, anorexia nervosa, malnutrition, Blicharz, L.; Rakowska, A.; Goldust, M.; Olszewska, M.; Rudnicka, L.
    [Show full text]
  • New Approach in Combined Therapy of Perifolliculitis Capitis Abscedens Et Suffodiens
    726 Letters to the Editor New Approach in Combined Therapy of Perifolliculitis Capitis Abscedens et Suffodiens Felix Jacobs, Gisela Metzler, Jakub Kubiak, Martin Röcken and Martin Schaller Department of Dermatology, Eberhard Karls University, DE-72076 Tuebingen, Germany. E-mail: [email protected] Accepted March 14, 2011. Perifolliculitis capitis abscedens et suffodiens (PCAS) tract. In the upper dermis there was a suppurative inflam- is a rare scalp disease seen mostly in young males of mation with abscess material and hair shaft fragments being discharged via a draining sinus. Periodic acid-Schiff (PAS) Afro-American descent. The disease is characterized by staining for fungi, as well as immunohistochemical staining perifollicular pustules, suppurative nodules and fluctua- with anti-Mycobacterium bovis (BCG) and for T. pallidum was ting abscesses, as well as by intercommunicating sinus negative. Direct immunofluorescence of the perilesional scalp tracts on the scalp. We report here an elderly Caucasian skin was negative. woman who fulfilled the clinical and histological criteria Microbiological examinations failed to identify pathogenic organisms. for diagnosis of PCAS. Following the diagnosis of a PCAS, the patient was treated The patient was treated with initial prednisolone, with 10 mg acitretin and 30 mg prednisolone daily as an inpa- systemic acitretin, topical tacrolimus and oral zinc. tient. The prednisolone was reduced to 5 mg per day during the After 6 months, her condition was stable. course of treatment. Because of the decreased level of zinc, 100 mg zinc aspartate was given daily. In addition, topical gluco- corticoids and tacrolimus 0.1% were alternated. CASE REPOrt This regimen produced almost total healing within 11 days (Fig.
    [Show full text]
  • EVIDENCE BASED UPDATE on the MANAGEMENT of ACNE Ep98 Jane Ravenscroft
    PHARMACY UPDATE Arch Dis Child Educ Pract Ed: first published as 10.1136/adc.2004.071183 on 21 November 2005. Downloaded from EVIDENCE BASED UPDATE ON THE MANAGEMENT OF ACNE ep98 Jane Ravenscroft Arch Dis Child Educ Pract Ed 2005;90:ep98–ep101. doi: 10.1136/adc.2004.071183 cne is an extremely common condition, affecting up to 80% of adolescents. Many cases are mild and may be considered ‘‘physiological’’, but others can be very severe and lead to Apermanent scarring. Paediatricians will frequently encounter acne in their practice, and have an important role in identifying and advising patients who require treatment. This review focuses on the practical management of acne from a paediatric perspective, with an emphasis on relating treatment decisions to currently available evidence. Many clinical trials of acne treatment have been carried out in the last 25 years, but they are of variable quality. Hence, there are grey areas, where treatment has to be guided by consensus opinion or clinical experience until better evidence is available. CLINICAL FEATURES AND AETIOLOGY Acne is a disease of pilosebaceous follicles. Under the influence of androgens, usually around puberty, the sebaceous glands enlarge and produce excess sebum. At the same time, keratinocytes in the sebaceous duct proliferate and cause blockage. These events lead to comedone formation. As a secondary event, Propionibacterium acnes (P acnes) colonise the comedones causing inflammation, which leads to papules and pustules. Clinically, acne usually affects the face first, with the back and chest affected in more severe cases. The lesions seen are blackheads (open comedones), whiteheads (closed comedones), copyright.
    [Show full text]